DENTIPATCH (lidocaine) by Noven Pharmaceuticals is clinical pharmacology mechanism of action: lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. First approved in 1996.
Drug data last refreshed 32m ago · AI intelligence enriched 2mo ago
DENTIPATCH is a buccal film formulation of lidocaine 5% approved in 1996 for topical anesthesia of oral mucous membranes. It works by stabilizing neuronal membranes to inhibit ionic fluxes required for impulse initiation and conduction, producing local anesthetic effects with onset in 3–5 minutes. The extended-release film delivery system enables sustained anesthesia at the site of application.
As a legacy topical anesthetic approaching loss of exclusivity with moderate competitive pressure (30), brand teams face declining revenues and rightsizing, limiting growth opportunities.
CLINICAL PHARMACOLOGY Mechanism of action: Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. Onset of anesthesia: Lidocaine Ointment 5% effects local, topical anesthesia. The…
Worked on DENTIPATCH at Noven Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Study to Assess Adverse Events and How Effective NOA LIFT is Compared to JUVÉDERM VOLIFT With Lidocaine for the Correction of Nasolabial Folds in Adults
Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region
Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias
Lidocaine for LESS Postoperative Shoulder Pain Alleviation
A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on DENTIPATCH offers limited career growth due to LOE status and generic competition; roles focus on cost management, market retention, and operational efficiency rather than expansion or innovation. Career advancement is constrained to specialty segments or transition to other products within the portfolio.